Bajaj Healthcare Limited

Web: bajajhealth.com NSE: BAJAJHCARE BSE: 539872 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

324 14(-4%)

Volume

2L as on 23, Jun

Open

569

High

589

Low

550

338

VWAP

316

52 Week High

489

52 Week Low

272

Viand Research Rating

Quality Score

57/100

Growth Score

64/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,091

No. of Shares

3.37

P/E

-80.33

P/B

4.48

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-5.58

ROCE

Profit Growth

Listing Date

25-Nov-21

Rank/Sector Rank

#1541/#123

Promoter Holding

58.58%

FII Holding

2.09%

DII Holding

1.96%

Price Chart

Price Performance

1 Week4%

1 Month3%

3 Months3%

6 Months0%

1 Year0%

YTD0%

Moving Average

5 Day SMA312

10 Day SMA304

20 Day SMA301

30 Day SMA299

50 Day SMA312

61 Day SMA312

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	328	320	325	327
Resistance 2	325	319	322	325
Resistance 1	321	318	321	321
Pivot Point	318	318	318	318
Support 1	315	317	316	315
Support 2	312	317	315	312
Support 3	309	316	312	308

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 58.58%	(0.31) 58.59%	(-0.91) 58.29%	(0.01) 59.19%	(0.01) 59.19%	(0.01) 59.19%	(0.01) 59.19%	(0.01) 59.19%	(-8.61) 59.19%	(0.01) 67.74%	(0.01) 67.74%	(0.01) 67.73%	(0.21) 67.69%	(0.01) 67.49%	(0.11) 67.49%	(0.11) 67.42%	(0.01) 67.30%	(0.01) 67.30%	(0.01) 67.26%	(0.01) 67.26%	(0.01) 67.26%
FIIs	(-0.11) 2.09%	(0.21) 2.19%	(0.81) 1.98%	(0.11) 1.18%	(0.01) 1.12%	(0.01) 1.09%	(0.01) 1.05%	(-0.11) 1.01%	(1.11) 1.07%	(-0.51) 0.00%	(-0.21) 0.53%	(0.11) 0.74%	(0.01) 0.66%	(-0.11) 0.69%	(-0.21) 0.78%	(0.91) 0.94%	(-0.21) 0.09%	(-0.11) 0.32%	(0.11) 0.38%	(0.01) 0.32%	(0.01) 0.34%
DIIs	(0.01) 1.96%	(-1.01) 1.92%	(0.01) 2.91%	(0.01) 2.96%	(-0.21) 2.99%	(0.61) 3.16%	(0.21) 2.52%	(0.41) 2.36%	(2.01) 1.97%	(-0.41) 0.00%	(-0.11) 0.43%	(0.11) 0.48%	(0.11) 0.43%	(0.01) 0.34%	(0.01) 0.34%	(0.31) 0.34%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	37.36%	37.30%	36.82%	36.67%	36.70%	36.56%	37.25%	37.45%	37.77%	32.27%	31.31%	31.06%	31.22%	31.48%	31.38%	31.30%	32.62%	32.38%	32.36%	32.42%	32.39%
No. of Shareholders	40,754	41,310	38,158	37,953	38,576	35,980	35,710	32,672	31,995	32,397	32,712	29,626	28,008	27,322	26,037	26,930	29,769	30,909	30,723	32,309	26,707

Quarterly Results

	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Sales	176	166	153	161	148	149	154	123	133	132	134	109	101	130	154	133	195	172	176	167.57
Sales Growth % (YoY)	18.9%	11.3%	-0.9%	31.3%	11.1%	12.5%	15.4%	13.1%	31.5%	1.9%	-13.1%	-18.1%	-48.2%	-24.6%	-	-	-	-	32.9%	-6%
Sales Growth % (QoQ)	6%	8.5%	-5%	8.8%	-0.7%	-3.2%	25.2%	-7.5%	0.8%	-1.5%	22.9%	7.9%	-22.3%	-15.6%	15.8%	-31.8%	13.4%	-2.3%	5%	-
Expenses	145	137	130	131	121	124	143	101	109	108	118	89	82	108	132	102	161	146	150	136.75
Operating Profit	31	29	23	31	27	25	12	22	25	24	16	20	19	22	22	30	34	26	25	30.82
OPM %	18	17	15	19	18	16	8	18	18	19	12	18	19	17	14	23	18	15	14	18.39
Other Income	1	1	-34	1	0	1	13	-1	4	0	-36	-7	-7	-55	-7	-6	-5	1	0	0.2
Interest	6	6	6	6	6	5	6	6	8	8	6	7	8	9	6	5	4	4	4	2.84
Depreciation	8	7	8	7	7	6	8	7	7	7	7	7	7	6	5	4	4	7	4	4.86
Profit before tax	18	16	-24	19	15	14	11	8	14	9	-33	-1	-3	-48	5	15	22	16	17	23.32
Tax %	23	16	-6	17	24	17	1	-39	30	23	-10	58	4	0	21	26	26	26	-3	25.21
Net Profit	14	14	-23	16	11	12	11	12	9	7	-30	-2	-3	-48	4	11	16	12	17	17.45
Net Profit Growth % (QoQ)	-	160.9%	-243.8%	45.5%	-8.3%	9.1%	-8.3%	33.3%	28.6%	123.3%	-1400%	33.3%	93.8%	-1300%	-63.6%	-31.2%	33.3%	-29.4%	-2.6%	-
Net Profit Growth % (YoY)	27.3%	16.7%	-309.1%	33.3%	22.2%	71.4%	136.7%	700%	400%	114.6%	-850%	-118.2%	-118.8%	-500%	-76.5%	-37%	-	-	-	-
TTM Net Profit	21	18	16	50	46	44	39	-2	-16	-28	-83	-49	-36	-17	43	56	62.45	46.45	34.45	0
EPS in Rs	4.19	4.07	-6.79	4.96	3.52	3.75	3.54	3.71	3	2.58	-10.84	-0.8	-1.25	-17.47	1.3	4	5.93	4.36	6.33	6.32

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	611	543	473	646	680	657	410	370	327	231	223	218	205	171
Sales Growth %	12.6%	14.6%	-26.7%	-5%	3.5%	60.2%	10.8%	13.2%	41.8%	3.5%	2.1%	6.5%	20%	20.7%
Expenses	506	460	397	534	561	521	362	327	288	200	193	189	186	158
Operating Profit	105	83	76	112	119	136	48	43	39	31	30	29	19	13
OPM %	17	15	16	17	17	21	12	12	12	13	14	13	9	7
Other Income	-32	16	-105	-19	1	7	7	1	2	2	0	0	0	0
Interest	22	28	30	18	13	8	7	8	8	8	8	8	7	6
Depreciation	28	28	28	17	18	16	12	11	11	11	9	9	9	8
Profit before tax	23	43	-86	58	90	119	36	24	23	14	14	12	3	-2
Tax %	33	7	-3	25	20	30	30	33	33	43	39	37	40	-31
Net Profit	16	40	-84	43	71	83	25	16	15	8	8	8	2	-1
Net Profit Growth %	-60%	147.6%	-295.3%	-39.4%	-14.5%	232%	56.2%	6.7%	87.5%	-	-	300%	300%	-
EPS in Rs	4.68	12.51	-30.36	15.59	25.87	30.11	9.14	5.91	5.5	2.83	3.04	2.78	2.19	-1.18
Dividend Payout %	32	8	-3	6	6	5	0	0	5	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	58	22	92	-22	1	44	21	25	17	22	25	28	17	14
Cash from Investing Activity	-48	-15	-11	-93	-75	-109	-28	-13	-12	-8	-31	-17	-9	-8
Cash from Financing Activity	24	-6	-97	131	62	75	3	-13	2	-13	5	-11	-8	-7
Net Cash Flow	35	0	-16	16	-12	10	-4	0	7	0	0	0	1	0

Balance Sheet

	Sep 2026	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	17	17	16	16	16	14	14	14	14	14	7	7	7	7	2	2	2
Reserves	540	516	471	450	430	265	354	315	245	164	122	107	92	82	78	28	26
Borrowings	282	249	238	223	206	333	415	257	181	91	81	87	75	81	70	72	72
Other Liabilities	142	141	114	144	152	154	115	136	86	74	57	68	45	39	38	43	31
Total Liabilities	981	923	839	833	804	765	898	721	526	343	267	268	219	209	189	145	131
Fixed Assets	263	248	251	238	240	253	366	270	208	162	128	127	128	130	108	56	54
CWIP	11	8	6	3	10	7	22	52	57	5	1	2	0	1	1	3	5
Investments	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0
Other Assets	708	667	582	591	554	506	510	399	260	170	137	140	91	78	79	87	72
Total Assets	981	923	839	833	804	765	898	721	526	343	267	268	219	209	189	145	131

Delivery

Delivery Data: BAJAJHCARE

#	Date	311 17% 364	Value (Cr)	Q/T 46	Del 48	Del 4
1	21-Oct	325	5	25	48	3
2	19-Oct	338	12	24	35	4
3	16-Oct	341	6	34	51	3
4	15-Oct	339	8	32	52	4
5	14-Oct	331	3	29	58	2
6	13-Oct	329	8	30	45	4
7	12-Oct	331	7	27	49	4
8	9-Oct	320	4	24	44	2
9	8-Oct	315	3	26	57	2
10	7-Oct	323	2	27	54	1
11	6-Oct	323	3	27	56	1
12	5-Oct	319	4	25	50	2
13	1-Oct	323	4	29	50	2
14	30-Sep	327	3	34	63	2
15	29-Sep	335	4	29	48	2
16	28-Sep	337	2	21	46	1
17	25-Sep	344	3	21	48	1
18	24-Sep	350	11	29	44	5
19	23-Sep	353	15	31	39	6
20	22-Sep	336	3	9	44	1
21	21-Sep	336	5	33	44	2
22	18-Sep	331	1	25	57	1
23	17-Sep	328	5	31	43	2
24	16-Sep	321	3	12	45	1
25	15-Sep	321	3	19	62	2
26	11-Sep	334	4	30	48	2
27	10-Sep	333	2	41	48	1
28	9-Sep	334	3	44	58	2
29	8-Sep	337	7	47	52	3
30	7-Sep	329	6	40	41	2
31	4-Sep	321	15	83	46	7
32	3-Sep	325	5	41	49	3
33	2-Sep	329	1	25	45	1
34	1-Sep	329	3	26	52	1
35	31-Aug	334	11	33	37	4
36	28-Aug	322	1	24	46	1
37	27-Aug	321	3	32	44	1
38	26-Aug	326	1	26	50	1
39	25-Aug	320	1	32	50	1
40	24-Aug	322	2	32	50	1
41	21-Aug	322	2	23	48	1
42	20-Aug	326	2	32	59	1
43	19-Aug	319	2	21	56	1
44	18-Aug	322	2	28	46	1
45	17-Aug	323	2	28	58	1
46	14-Aug	329	2	28	58	1
47	13-Aug	331	5	38	33	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	1,091c	54c	4.68
19-Oct	1,144c	24c	2.05
17-Oct	1,168c	0	0
16-Oct	1,168c	24c	2.10
15-Oct	1,144c	34c	3.02
14-Oct	1,111c	2c	0.15
13-Oct	1,112c	34L	0.03
12-Oct	1,112c	38c	3.51
09-Oct	1,074c	17c	1.62
08-Oct	1,057c	30c	2.79
05-Oct	1,087c	2c	0.16
01-Oct	1,086c	40c	3.57
29-Sep	1,126c	9c	0.76
28-Sep	1,135c	27c	2.32
25-Sep	1,161c	52c	4.26
24-Sep	1,213c	75c	6.63
22-Sep	1,138c	30c	2.74
17-Sep	1,107c	19c	1.70
10-Sep	1,127c	26c	2.34
07-Sep	1,101c	0	0

Stock Checklist

Price is above from 52 week high low average: 24%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 4 fund scheme(s) across 2 fund house(s) as of Oct26 · Total value ₹37 Cr · 0 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	2	0.53%	-0.04%	37.2
Bandhan Mutual Fund	2	0.05%	-	0

Bajaj Healthcare Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements